Globus Medical, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $0.56 | $0.57 | $0.57 |
Q2 2024 | 6 | $0.68 | $0.68 | $0.68 |
Q3 2024 | 4 | $0.65 | $0.65 | $0.65 |
Q4 2024 | 11 | $0.67 | $0.83 | $0.74 |
Q1 2025 | 7 | $0.76 | $0.83 | $0.78 |
Q2 2025 | 3 | $0.86 | $0.88 | $0.87 |
Q3 2025 | 6 | $0.84 | $0.86 | $0.85 |
Q4 2025 | 5 | $0.88 | $0.90 | $0.89 |
Q1 2026 | 4 | $0.94 | $0.96 | $0.95 |
Q2 2026 | 3 | $0.99 | $1.01 | $1.00 |
Q3 2026 | 2 | $0.98 | $1.00 | $0.99 |
Q4 2026 | 2 | $1.01 | $1.03 | $1.02 |
Globus Medical, Inc. Earnings Date And Information
Globus Medical, Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $0.83 earnings per share for the quarter, topping analysts' consensus estimates of $0.65 by $0.18. The company had revenue of 625.71 M for the quarter and had revenue of 1.57 B for the year. Globus Medical, Inc. has generated $1 earnings per share over the last year ($1.07 diluted earnings per share) and currently has a price-to-earnings ratio of 125.83. Globus Medical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based on prior year's report dates.
Globus Medical, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/05/2024 | Q3 2024 | $0.65 | $0.38 | -0.27 | $604.69 M | $625.71 M |
08/06/2024 | Q2 2024 | $0.68 | $0.23 | -0.45 | $615.33 M | $629.69 M |
05/07/2024 | Q1 2024 | $0.57 | -$0.05 | -0.62 | $606.67 M | |
02/20/2024 | Q4 2023 | $0.11 | $616.53 M | |||
11/07/2023 | Q3 2023 | $0.54 | $0.01 | -0.53 | $306.78 M | $383.64 M |
08/03/2023 | Q2 2023 | $0.59 | $0.57 | -0.02 | $279.54 M | $291.62 M |
05/04/2023 | Q1 2023 | $0.51 | $0.49 | -0.02 | $276.69 M | |
03/16/2023 | Q4 2022 | $0.50 | $274.50 M | |||
11/08/2022 | Q3 2022 | $0.52 | $0.48 | -0.04 | $253.40 M | $254.15 M |
08/04/2022 | Q2 2022 | $0.53 | $0.54 | 0.01 | $259.38 M | $263.65 M |
05/10/2022 | Q1 2022 | $0.47 | $0.37 | -0.1 | $230.55 M | |
02/17/2022 | Q4 2021 | $0.48 | $0.15 | -0.33 | $250.02 M | |
11/04/2021 | Q3 2021 | $0.45 | $0.47 | 0.02 | $228.29 M | $229.72 M |
08/04/2021 | Q2 2021 | $0.45 | $0.41 | -0.04 | $225.50 M | $251.02 M |
05/04/2021 | Q1 2021 | $0.37 | $0.45 | 0.08 | $227.34 M | |
02/17/2021 | Q4 2020 | $0.51 | $0.54 | 0.03 | $233.45 M | |
10/28/2020 | Q3 2020 | $0.30 | $0.45 | 0.15 | $196.10 M | $216.10 M |
08/05/2020 | Q2 2020 | -$0.11 | -$0.21 | -0.1 | $103.55 M | $148.92 M |
05/07/2020 | Q1 2020 | $0.38 | $0.26 | -0.12 | $190.58 M | |
02/20/2020 | Q4 2019 | $0.52 | $0.46 | -0.06 | $211.67 M |
Globus Medical, Inc. Earnings: Frequently Asked Questions
-
When is Globus Medical, Inc.'s earnings date?
Globus Medical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates.
-
Did Globus Medical, Inc. beat their earnings estimates last quarter?
In the previous quarter, Globus Medical, Inc. (:GMED) reported $0.83 earnings per share (EPS) to beat the analysts' consensus estimate of $0.65 by $0.18.
-
How can I listen to Globus Medical, Inc.'s earnings conference call?
The conference call for Globus Medical, Inc.'s latest earnings report can be listened to online.
-
How can I read Globus Medical, Inc.'s conference call transcript?
The conference call transcript for Globus Medical, Inc.'s latest earnings report can be read online.
-
How much revenue does Globus Medical, Inc. generate each year?
Globus Medical, Inc. (:GMED) has a recorded annual revenue of $1.57 B.
-
How much profit does Globus Medical, Inc. generate each year?
Globus Medical, Inc. (:GMED) has a recorded net income of $1.57 B. Globus Medical, Inc. has generated $1.09 earnings per share over the last four quarters.
-
What is Globus Medical, Inc.'s price-to-earnings ratio?
Globus Medical, Inc. (:GMED) has a price-to-earnings ratio of 125.83 and price/earnings-to-growth ratio is 1.02.